Furthermore, genistein decreases phosphorylated-Akt in HT-29 colon cancer cells [292], in LNCaP prostate cancer cells [293], and in HeLa and CaSki cervical cancer cell lines [294], as well as in other cancer cell cultures [272]. This evidence concerns the gene AKT1 and cervical cancer.